Press Release ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting 22 April 2024
Press Release Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting 22 April 2024
Press Release Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 22 April 2024
Press Release Driven Brands Holdings Inc. to host first quarter earnings conference call on May 2, 2024 22 April 2024
Press Release Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) 22 April 2024
Press Release Vesigen to Present New Preclinical Data on Engineered ARMMs Technology at 2024 ASGCT Annual Meeting 22 April 2024
Press Release 8×8, Inc. Schedules Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call 22 April 2024
Press Release Beacon Appoints Prithvi Gandhi as Executive Vice President and Chief Financial Officer 22 April 2024
